Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human ABCG2 Stable Cell Line

    [CAT#: S01YF-1123-KX116]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Transporter Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-0922-KX1555 Magic™ Human ABCG2 in Vitro Drug screening assay Human Caco-2, MDCK, HEK293, CHO, membrane vesicles, and various transfected cells lines Activity Assay (High throughput screening assays; Large scale single dose, duplicate profiling; IC50 profiling; Ki determination assay; Substrate determination assay )

    Product Information

    Target Protein
    ABCG2
    Target Family
    ABC Transporter
    Target Protein Species
    Human
    Host Cell Type
    NSCLC; CHO-K1; HEK293
    Target Classification
    Transporter Cell Lines
    Target Research Area
    Cancer Research; Metabolic Research
    Related Diseases
    Uric Acid Concentration; Blood Group
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The ATP-binding cassette gene family, which includes the ABCG2 gene, offers instructions for producing proteins that carry chemicals across cell membranes. The ABCG2 protein aids in the intestines' release (secretion) of urate into the urine. It functions as an antioxidant in the bloodstream, shielding cells from the corrosive effects of unstable molecules known as free radicals. The kidneys and, to a lesser extent, the intestines control the amounts of urea. Certain medications are also transported out of cells via the ABCG2 protein. This protein, for instance, removes certain chemotherapy medications from tissues and organs. These medications' transportation enables both their intended effects and bodily elimination. The customized ABCG2 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Ashley

    The ABCG2 cell line is a good product for general routine use from Creative Biolabs. Sep 01 2022

    chat Verified Customer

    chat Gary

    I recently purchased the human ABCG2 cell line, and it has been a valuable tool in my laboratory work for drug screening. Jul 06 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Characterization of ABCG2 expression and activity in NSCLC cell lines.

    50μg of proteins were put into lysed cells in order to evaluate ABCG2 protein expression using western blot analysis. The information comes from a typical experiment. Three repetitions of each experiment produced findings that were comparable.

    Ref: Galetti, Maricla, et al. "Effect of ABCG2/BCRP expression on efflux and uptake of gefitinib in NSCLC cell lines." PloS one 10.11 (2015): e0141795.

    Pubmed: 26536031

    DOI: 10.1371/journal.pone.0141795

    Research Highlights

    A constitutively expressed ATP-binding cassette (ABC) transporter, ABCG2 shields a variety of organs from outside substances. Its action impacts the pharmacokinetics of widely used medications and restricts the penetration of treatments into cancerous cells, hence fostering multidrug resistance.
    Taylor, Nicholas MI, et al. "Structure of the human multidrug transporter ABCG2." Nature 546.7659 (2017): 504-509.
    Pubmed: 28554189   DOI: 10.1038/nature22345

    It is acknowledged that ABCG2 plays a significant role in determining the pharmacokinetic properties of the medicines that it substrates. An adequate modification of ABCG2 function during chemotherapy should logically boost the efficacy of anti-cancer medicines by overcoming the MDR phenotype and/or increasing their pharmacokinetics, even though the therapeutic implications of reversing the ABCG2-mediated MDR has proved unconvincing.
    Toyoda, Yu, Tappei Takada, and Hiroshi Suzuki. "Inhibitors of human ABCG2: from technical background to recent updates with clinical implications." Frontiers in pharmacology 10 (2019): 208.
    Pubmed: 30890942   DOI: 10.3389/fphar.2019.00208

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare